<DOC>
	<DOCNO>NCT00809497</DOCNO>
	<brief_summary>The main objective study evaluate effectiveness safety propionyl-L-carnitine hydrochloride tablet among Chinese population comparison placebo , treatment peripheral arterial disease ( intermittent claudication ) oral supplementation 2g daily 4 month continuous administration .</brief_summary>
	<brief_title>A Clinical Study Efficacy &amp; Safety Profile Propionyl-L-carnitine Tablets Peripheral Arterial Diseases</brief_title>
	<detailed_description>This randomize , multi-centre , double-blind placebo control clinical study . Propionyl-L-Carnitine ( PLC ) kind natural derivative L-Carnitine ( LC ) produce body concentrate 90 % skeletal muscle myocardium via enzyme-mediated reaction involve propionyl-CoA LC . For oral adminsitration , PLC show decrease leg muscle carnitine PAD patient appear correlate poor exercise performance . It recently show severity impairment walk distance correlate impairment carntine metabolism muscle level . 2g daily PLC supplementation significantly improve walk ability patient IC maximum walking capacity 50 250 meter treadmill .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>The variability two standardized claudication test washout period must &lt; 20 % , assess formular : ( Highest MWDLowest MWD ) / ( Lowest MWDxx100 % ) At last visit washout period , ABI rest must ,0.9 rest pain , ulceration , and/or gangrene PAD nonatherosclerotic nature Aortic low extremity arterial surgery , angioplasty , lumbar sympathectomy within 6 month ; ankle level amputation . Any type major surgery last three month . Except PAD , concomitant disease limit patient ' performance treadmill exercise . angina ( rest activity ) symptom sufficiently severe discontinue treadmill exercise . Myocardial infarction within 6 month Severe cerebral dysfunction Type I diabetes ( Stable type II diabetes also include ) alcohol drug abuse history within 3 month Medium severe anaemia ( Hb,90g/L ) Platelets &lt; 100 x 10 9/L Bleeding diathesis Renal insufficiency hepatic function laboratory test result &gt; 1.5 normal value Treatment LC carnitien derivative past 3 month Pregnancy , lactation , fertility without adequate protest pregnancy Reject sign inform consent form</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>PLC treatment peripheral arterial disease</keyword>
</DOC>